Gallant VR Implantable Cardioverter Defibrillator REF # CDVRA500Q
FDA Recall Z-0989-2022 · Posted None
Advertisement
Recalling FirmSt. Jude Medical, Cardiac Rhythm Management Division
Recall StatusOpen, Classified
Product CodeLWS
Date Initiated2022-03-10
Product Quantity2
Reason for Recall
Bluetooth malfunction impacting Gallant devices post-implant. The failure causes the device to
enter an inductive-only telemetry mode with a loss of Bluetooth communication. The Bluetooth malfunction results in the inability to remotely monitor these devices and resulted in reduced battery longevity.
Firm Action
Abbott issued a Safety Notification For a subset of Gallant ICDS and CRT-D, Models CDVRA500Q, CDDRA500Q and CDHFA500Q on March 10, 2022. Notification was hand delivered in US.
The notification includes the Patient Management Recommendations:
-As the devices are unable to be followed using remote monitoring via Bluetooth connectivity, follow-ups should be conducted in-clinic using inductive telemetry.
- Abbott has developed a process to attempt recovery of Bluetooth communication via a device firmware upgrade. If remote monitoring via Bluetooth communication is desired, please work with your local Abbott representative to schedule a firmware upgrade.
Please complete and return the included Acknowledgement Form to [email protected] and maintain a record of this notice to ensure
effectiveness of the communication.
For any question, please contact Abbott Technical Support at 1-800-722-3774 (U.S.).
Root Cause
Component design/selection
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of FL, KY and the country of France, Czech Republic.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement